Adenocarcinoma of lung (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
Upregulated microRNA miR-21 promotes the progression of lung adenocarcinoma through inhibition of KIBRA and the Hippo signaling pathway.
|
30372890 |
2018 |
Alcohol or Other Drugs use
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
GABRA2 and KIBRA genotypes predict early relapse to substance use.
|
22129841 |
2012 |
Alzheimer Disease, Late Onset
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The rs17070145-T variant of the WWC1 gene, coding for the KIBRA protein, has been associated with both increased episodic memory performance and lowered risk for late onset Alzheimer's disease, although the mechanism behind this protective effect has not been completely elucidated.
|
28380666 |
2017 |
Alzheimer Disease, Late Onset
|
0.020 |
Biomarker
|
disease |
BEFREE |
Evidence for an association between KIBRA and late-onset Alzheimer's disease.
|
18789830 |
2010 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
KIBRA single nucleotide polymorphism (rs17070145) has been linked to episodic memory performance as well as an increased risk of Alzheimer's disease and post-traumatic stress disorder (PTSD).
|
30134813 |
2018 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our data suggested that KIBRA might associate with younger AD patients (≤74 years) in a Northern Han Chinese population.
|
24190487 |
2013 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Genetic variations of APOE and KIBRA have been associated with human memory and Alzheimer's disease.
|
27620974 |
2017 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our findings suggest that KIBRA is associated with both individual variation in normal episodic memory and predisposition to AD.
|
18789830 |
2010 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The association between KIBRA polymorphisms and the DMN and ECN should be further explored in a healthy older population and in patients with AD.
|
23266749 |
2013 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
<b>Methods</b>: The AD animal model (APP/PS1 transgenic mice) and KIBRA knockout (KIBRA KO) mice were used to investigate pathophysiological changes of KIBRA <i>in vivo</i>.
|
31031595 |
2019 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The current study reveals that KIBRA (rs17070145) T allele (CT and TT genotypes) is associated with an increased risk (OR 2.89; p=0.03) for very-late-onset (after the age of 86 years) AD.
|
17707552 |
2009 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
In functional studies, WW and C2 domain containing 1, aka KIBRA and TLN2 coexpressed in the temporal cortex brain tissue of AD subjects (β=0.17, 95% CI 0.04 to 0.30, p=0.01); modulated Tau toxicity in Drosophila eye experiments; colocalized in brain tissue cells, N2a neuroblastoma, and HeLa cell lines; and coimmunoprecipitated both in brain tissue and HEK293 cells.
|
30201328 |
2018 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The human KIBRA gene has been linked to human cognition through a lead intronic single-nucleotide polymorphism (SNP; rs17070145) that is associated with episodic memory performance and the risk to develop Alzheimer's disease.
|
23778582 |
2013 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our Cross-sectional investigation of 312 adults aged 50-89 years free of dementia included genotyping of the KIBRA rs17070145 gene and the assessment of episodic memory to Establish a Registry for Alzheimer's Disease (CERAD).
|
18194457 |
2009 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These findings suggest that healthy older people have additive and epistatic interactions of KIBRA and APOE gene variants, which modulate brain FNC and may partly elucidate their association with episodic memory performance and AD.
|
30715155 |
2019 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our results evidence a strong association between the KIBRA gene and episodic memory impairment in AD, but show no influence on AD in our Japanese cohort.
|
20881395 |
2010 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
These results suggest a modest role for KIBRA as a cognition and AD risk gene, and also highlight the multifactorial complexity of its genetic associations.
|
21185624 |
2011 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Association of KIBRA polymorphism with risk of Alzheimer's disease: Evidence based on 20 case-control studies.
|
28859866 |
2018 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Functional studies suggest that KIBRA is a potential candidate gene for memory and Alzheimer's disease (AD) risk.
|
25800888 |
2015 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Recent studies have implicated the involvement of a genetic variation in the KIBRA gene (T allele) in human memory in normal subjects and in the risk of developing Alzheimer's disease (AD).
|
18378080 |
2008 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The first genome-wide association study of human memory identified an association between a common T/C polymorphism of the KIBRA gene (rs17070145) and episodic memory performance in normal individuals; subsequent studies have implicated the same polymorphism in Alzheimer's disease.
|
20185150 |
2010 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Alterations of Kibra-encoding gene WWC1 cause various neuronal disorders, including Alzheimer's disease and Tourette syndrome.
|
30784589 |
2019 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, our results suggest that the effect of the WWC1 rs17070145 polymorphism on memory performance and Alzheimer's disease might be due to a differential regulation of the MAPK signaling, a key pathway involved in memory and learning processes.
|
28380666 |
2017 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
There is a lack of consensus on the effect of KIBRA gene variants on cognitive performances in episodic memory and on the risk of AD.
|
30953258 |
2019 |
Amnesia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here we report abnormal acetylation of K274 and K281 on tau, identified in AD brains, promotes memory loss and disrupts synaptic plasticity by reducing postsynaptic KIdney/BRAin (KIBRA) protein, a memory-associated protein.
|
27041503 |
2016 |